TD Bank (NYSE: TD) discloses 5.2% ownership of PTC Therapeutics (PTCT) shares

Rhea-AI Filing Summary

The Toronto-Dominion Bank has reported a significant ownership stake in PTC Therapeutics, Inc. The bank beneficially owns 4,138,215 shares of PTC Therapeutics common stock, representing 5.2% of the outstanding class as of 12/31/2025.

TD Bank reports sole power to vote and dispose of all 4,138,215 shares, with no shared voting or dispositive power. The bank states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of PTC Therapeutics.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PTC THERAPEUTICS, INC.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

69366J200

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 69366J200

1

Names of Reporting Persons

The Toronto-Dominion Bank

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CANADA (FEDERAL LEVEL)

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,138,215.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,138,215.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,138,215.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.2 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PTC THERAPEUTICS, INC.
(b)	Address of issuer's principal executive offices: 500 WARREN CORPORATE CENTER DRIVE, WARREN, NEW JERSEY 07059
Item 2.
(a)	Name of person filing: The Toronto-Dominion Bank
(b)	Address or principal business office or, if none, residence: 66 Wellington Street West 12th Floor TD Tower Toronto, Ontario, Canada M5K 1A2
(c)	Citizenship: The Toronto-Dominion Bank - CANADA (FEDERAL LEVEL)
(d)	Title of class of securities: Common Stock, $0.001 par value per share
(e)	CUSIP No.: 69366J200
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	Bank
Item 4.	Ownership
(a)	Amount beneficially owned: 4,138,215
(b)	Percent of class: 5.2 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The Toronto-Dominion Bank - 4,138,215
	(ii) Shared power to vote or to direct the vote: The Toronto-Dominion Bank - 0
	(iii) Sole power to dispose or to direct the disposition of: The Toronto-Dominion Bank - 4,138,215
	(iv) Shared power to dispose or to direct the disposition of: The Toronto-Dominion Bank - 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Toronto-Dominion Bank

Signature:	Christina Petrou
Name/Title:	Christina Petrou / Executive Vice President and Chief Operating Officer
Date:	02/13/2026

FAQ

What percentage of PTC Therapeutics (PTCT) does The Toronto-Dominion Bank own?

The Toronto-Dominion Bank owns 5.2% of PTC Therapeutics’ common stock. This corresponds to 4,138,215 shares of common stock as of December 31, 2025, giving the bank a reportable stake above the 5% regulatory disclosure threshold.

How many PTC Therapeutics (PTCT) shares are beneficially owned by The Toronto-Dominion Bank?

The Toronto-Dominion Bank beneficially owns 4,138,215 shares of PTC Therapeutics common stock. The bank reports sole voting and sole dispositive power over this entire block of shares, with no shared voting or shared dispositive authority reported.

Does The Toronto-Dominion Bank control voting rights for its PTCT shares?

Yes. The Toronto-Dominion Bank reports sole power to vote 4,138,215 PTCT shares and sole power to dispose of the same number. It reports zero shared voting power and zero shared dispositive power over PTC Therapeutics common stock.

Why did The Toronto-Dominion Bank file a Schedule 13G for PTC Therapeutics (PTCT)?

The bank filed Schedule 13G because it beneficially owns more than 5% of PTCT common stock. It certifies the shares were acquired and are held in the ordinary course of business, not to change or influence control of PTC Therapeutics.

Is The Toronto-Dominion Bank seeking to influence control of PTC Therapeutics (PTCT)?

No. The filing states the PTCT shares were acquired and are held in the ordinary course of business and were not acquired, and are not held, for the purpose of changing or influencing the control of PTC Therapeutics in any way.

What type of reporting person is The Toronto-Dominion Bank in the PTCT Schedule 13G?

The Toronto-Dominion Bank is identified as a bank reporting person. It is organized under Canada (federal level) and files under the Schedule 13G framework applicable to institutions, disclosing its beneficial ownership position in PTC Therapeutics common stock.